103 related articles for article (PubMed ID: 29174182)
1. Corrigendum to "Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer" [Eur J Cancer 40 (18) (2004) 2717-2725].
Martin TA; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2018 Jan; 88():115-116. PubMed ID: 29174182
[No Abstract] [Full Text] [Related]
2. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer.
Martin TA; Watkins G; Mansel RE; Jiang WG
Eur J Cancer; 2004 Dec; 40(18):2717-25. PubMed ID: 15571953
[TBL] [Abstract][Full Text] [Related]
3. Corrigendum to "De novo metastatic breast cancer in patients with a small locoregional tumour (T1-T2/N0): characteristics and prognosis" [Eur J Cancer 158 (2021) 181-188].
Gaillard T; Carton M; Mailliez A; Desmoulins I; Mouret-Reynier MA; Petit T; Leheurteur M; Dieras V; Ferrero JM; Uwer L; Guiu S; Gonc Alves A; Levy C; Debled M; Dalenc F; Patsouris A; Bachelot T; Eymard JC; Chevrot M; Conversano A; Robain M; Hequet D
Eur J Cancer; 2022 May; 166():311-312. PubMed ID: 35314113
[No Abstract] [Full Text] [Related]
4. Corrigendum to "Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy" [Eur J Cancer 75 (April 2017) 109-116].
Puliti D; Bucchi L; Mancini S; Paci E; Baracco S; Campari C; Canuti D; Cirilli C; Collina N; Conti GM; Di Felice E; Falcini F; Michiara M; Negri R; Ravaioli A; Sassoli De' Bianchi P; Serafini M; Zorzi M; Caldarella A; Cataliotti L; Zappa M;
Eur J Cancer; 2017 Nov; 85():160. PubMed ID: 28870467
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Tumor suppression effects of myoepithelial cells on mice breast cancer" [Eur. J. Pharmacol. 765 (2015) 171-178].
Farhangi B; Latifpour M; Alizadeh AM; Khodayari H; Khodayari S; Khaniki M; Ghasempour S
Eur J Pharmacol; 2016 Jul; 782():119. PubMed ID: 27180042
[No Abstract] [Full Text] [Related]
6. Corrigendum to "Immunohistochemical subtypes predict survival in metastatic breast cancer receiving high-dose chemotherapy with autologous haematopoietic stem cell transplantation" [Eur J Cancer 57 (April 2016) 118-126].
Boudin L; Chabannon C; Sfumato P; Sabatier R; Bertucci F; Tarpin C; Provansal M; Houvenaeghel G; Lambaudie E; Tallet A; Resbeut M; Charafe-Jauffret E; Calmels B; Lemarie C; Boher JM; Extra JM; Viens P; Gonçalves A
Eur J Cancer; 2016 Nov; 67():223. PubMed ID: 27680408
[No Abstract] [Full Text] [Related]
7. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135].
Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiraga N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
Eur J Radiol; 2019 May; 114():192. PubMed ID: 30954326
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Less-favourable prognosis for low-risk endometrial cancer patients with a discordant pre- versus post-operative risk stratification" [Eur J Cancer 78 (2017) 82-90].
Eggink FA; Mom CH; Bouwman K; Boll D; Becker JH; Creutzberg CL; Niemeijer GC; van Driel WJ; Reyners AK; van der Zee AG; Bremer GL; Ezendam NP; Kruitwagen RF; Pijnenborg JM; Hollema H; Nijman HW; van der Aa MA
Eur J Cancer; 2017 Oct; 84():370. PubMed ID: 28844347
[No Abstract] [Full Text] [Related]
9. Hepatocyte growth factor disrupts tight junctions in human breast cancer cells.
Martin TA; Watkins G; Mansel RE; Jiang WG
Cell Biol Int; 2004; 28(5):361-71. PubMed ID: 15193279
[TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint
Makama M; Drukker CA; Rutgers EJT; Slaets L; Cardoso F; Rookus MA; Tryfonidis K; Van't Veer LJ; Schmidt MK
Eur J Cancer; 2018 Jun; 96():131-132. PubMed ID: 29656866
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Preoperative breast cancer staging with multi-modality imaging and surgical outcomes" [Eur. J. Radiol. 122 (2020) 108766].
Mariscotti G; Durando M; Tagliafico A; Campanino PP; Bosco D; Casella C; Bussone R; Ala A; Castellano I; Sapino A; Bergamasco L; Fonio P; Houssami N
Eur J Radiol; 2020 May; 126():108919. PubMed ID: 32197783
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Discovery of novel nonsteroidal VDR agonists with novel diarylmethane skeleton for the treatment of breast cancer" [Eur. J. Med. Chem. 163 (2019) 787-803].
Wang C; Wang B; Hou S; Xue L; Kang Z; Du J; Li Y; Liu X; Wang Q; Zhang C
Eur J Med Chem; 2020 Jan; 186():111907. PubMed ID: 31791642
[No Abstract] [Full Text] [Related]
13. Expression and function of tight junction associated molecules in human breast tumor cells is not affected by the Ras-MEK1 pathway.
Macek R; Swisshelm K; Kubbies M
Cell Mol Biol (Noisy-le-grand); 2003 Feb; 49(1):1-11. PubMed ID: 12839332
[TBL] [Abstract][Full Text] [Related]
14. Corrigendum to "Hsp90 chaperone facilitates E2F1/2-dependent gene transcription in human breast cancer cells" [Eur. J. Cell Biol. 100 (2021) 151148].
Kotwal A; Suran S; Amere Subbarao S
Eur J Cell Biol; 2021 Apr; 100(3):151157. PubMed ID: 33744515
[No Abstract] [Full Text] [Related]
15. Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.
Martin TA; Jiang WG
Methods Mol Biol; 2011; 762():383-407. PubMed ID: 21717372
[TBL] [Abstract][Full Text] [Related]
16. Corrigendum to "Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction - A prospective randomized trial" [Eur J Surg Oncol 42 (5) (2016) 665-671].
Gschwantler-Kaulich D; Schrenk P; Bjelic-Radisic V; Unterrieder K; Leser C; Fink-Retter A; Salama M; Singer C
Eur J Surg Oncol; 2017 Jul; 43(7):1380-1381. PubMed ID: 28526188
[No Abstract] [Full Text] [Related]
17. Corrigendum to "Artificial intelligence in computed tomography plaque characterization: A review" [Eur. J. Radiol. 140 (2021) 109767].
Cau R; Flanders A; Mannelli L; Politi C; Faa G; Suri JS; Saba L
Eur J Radiol; 2022 Feb; 147():110132. PubMed ID: 34998099
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Avoidable cancer cases in the Nordic countries - The impact of overweight and obesity" [Eur J Cancer 79 (2017) 106-118].
Andersson TM; Weiderpass E; Engholm G; Lund AQ; Olafsdottir E; Pukkala E; Stenbeck M; Storm H
Eur J Cancer; 2017 Dec; 87():219-220. PubMed ID: 29029964
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087].
van Nijnatten TJA; Payne NR; Hickman SE; Ashrafian H; Gilbert FJ
Eur J Radiol; 2024 Jan; 170():111202. PubMed ID: 37988959
[No Abstract] [Full Text] [Related]
20. Corrigendum to "2nd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of rectal cancer" [Eur J Cancer 63 (August 2016) 11-24].
Lutz MP; Zalcberg JR; Glynne-Jones R; Ruers T; Ducreux M; Arnold D; Aust D; Brown G; Bujko K; Cunningham C; Evrard S; Folprecht G; Gerard JP; Habr-Gama A; Haustermans K; Holm T; Kuhlmann KF; Lordick F; Mentha G; Moehler M; Nagtegaal ID; Pigazzi A; Pucciarelli S; Roth A; Rutten H; Schmoll HJ; Sorbye H; Van Cutsem E; Weitz J; Otto F
Eur J Cancer; 2016 Nov; 68():208-209. PubMed ID: 27717654
[No Abstract] [Full Text] [Related]
[Next] [New Search]
